Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Opicapone

Opicapone Editorial Opinion [published online December 27, 2016]. JAMA Neurol. Sclerosis. Amyotrophic lateral sclerosis outcome and outcome in Guillain-Barré syndrome. Ann Neurol. doi:10.1001/jamaneurol.2016.4480 measures and the role of albumin and creatinine: 2009;66(5):597-603. a population-based study. JAMA Neurol. 2014;71(9): 4. International Guillain-Barré Syndrome Outcome 13. Petzold A, Brettschneider J, Jin K, et al. CSF 1134-1142. Study (IGOS). https://gbsstudies.erasmusmc.nl protein biomarkers for proximal axonal damage /about-igos. Accessed September 22, 2016. 9. van den Berg B, van der Eijk AA, Pas SD, et al. improve prognostic accuracy in the acute phase of Guillain-Barré syndrome associated with preceding Guillain-Barré syndrome. Muscle Nerve. 2009;40 5. Walgaard C, Lingsma HF, Ruts L, van Doorn PA, hepatitis E virus infection. Neurology. 2014;82(6): (1):42-49. Steyerberg EW, Jacobs BC. Early recognition of 491-497. poor prognosis in Guillain-Barré syndrome. 14. Halstead SK, Zitman FM, Humphreys PD, et al. Neurology. 2011;76(11):968-975. 10. Willison HJ, Jacobs BC, van Doorn PA. Eculizumab prevents anti-ganglioside Guillain-Barré syndrome. Lancet. 2016;388 antibody-mediated neuropathy in a murine model. 6. Walgaard C, Lingsma HF, Ruts L, et al. Prediction (10045):717-727. Brain. 2008;131(pt 5):1197-1208. of respiratory insufficiency in Guillain-Barré syndrome. Ann Neurol. 2010;67(6):781-787. 11. Hadden RDM, Karch H, Hartung H-P, et al; 15. McGonigal R, Cunningham ME, Yao D, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Neurology American Medical Association

Loading next page...
 
/lp/american-medical-association/opicapone-a48HQVNaND
Publisher
American Medical Association
Copyright
Copyright 2016 American Medical Association. All Rights Reserved.
ISSN
2168-6149
eISSN
2168-6157
DOI
10.1001/jamaneurol.2016.5012
pmid
28027328
Publisher site
See Article on Publisher Site

Abstract

Editorial Opinion [published online December 27, 2016]. JAMA Neurol. Sclerosis. Amyotrophic lateral sclerosis outcome and outcome in Guillain-Barré syndrome. Ann Neurol. doi:10.1001/jamaneurol.2016.4480 measures and the role of albumin and creatinine: 2009;66(5):597-603. a population-based study. JAMA Neurol. 2014;71(9): 4. International Guillain-Barré Syndrome Outcome 13. Petzold A, Brettschneider J, Jin K, et al. CSF 1134-1142. Study (IGOS). https://gbsstudies.erasmusmc.nl protein biomarkers for proximal axonal damage /about-igos. Accessed September 22, 2016. 9. van den Berg B, van der Eijk AA, Pas SD, et al. improve prognostic accuracy in the acute phase of Guillain-Barré syndrome associated with preceding Guillain-Barré syndrome. Muscle Nerve. 2009;40 5. Walgaard C, Lingsma HF, Ruts L, van Doorn PA, hepatitis E virus infection. Neurology. 2014;82(6): (1):42-49. Steyerberg EW, Jacobs BC. Early recognition of 491-497. poor prognosis in Guillain-Barré syndrome. 14. Halstead SK, Zitman FM, Humphreys PD, et al. Neurology. 2011;76(11):968-975. 10. Willison HJ, Jacobs BC, van Doorn PA. Eculizumab prevents anti-ganglioside Guillain-Barré syndrome. Lancet. 2016;388 antibody-mediated neuropathy in a murine model. 6. Walgaard C, Lingsma HF, Ruts L, et al. Prediction (10045):717-727. Brain. 2008;131(pt 5):1197-1208. of respiratory insufficiency in Guillain-Barré syndrome. Ann Neurol. 2010;67(6):781-787. 11. Hadden RDM, Karch H, Hartung H-P, et al; 15. McGonigal R, Cunningham ME, Yao D,

Journal

JAMA NeurologyAmerican Medical Association

Published: Feb 27, 2017

References